These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2442555)

  • 1. Long-term monotherapy with lisinopril in renovascular hypertension.
    Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Junggren IL
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S61-5. PubMed ID: 2442555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension.
    Karlberg BE; Rosenqvist U
    Acta Med Scand Suppl; 1986; 714():33-42. PubMed ID: 3033998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of lisinopril in elderly patients with mild to moderate hypertension.
    Marlier R; Vandepapelière P; De Vriese G
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():163-7. PubMed ID: 2550639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive and renal effects of lisinopril in older patients with hypertension.
    Laher MS; Donohoe JF; Kelly JG; Doyle GD
    Am J Med; 1988 Sep; 85(3B):38-43. PubMed ID: 2844086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
    Espinel CH; Williams JL; Coughlin SS
    Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension.
    Jackson B; McGrath BP; Matthews PG; Wong C; Johnston CI
    Hypertension; 1986 Aug; 8(8):650-4. PubMed ID: 3015794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisinopril in the treatment of hypertensive patients with renal impairment.
    Donohoe JF; Kelly J; Laher MS; Doyle GD
    Am J Med; 1988 Sep; 85(3B):31-4. PubMed ID: 2844084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.
    Herpin D; Conte D
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():11-5. PubMed ID: 2550634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisinopril in hypertensive patients with and without renal failure.
    van Schaik BA; Geyskes GG; Boer P
    Eur J Clin Pharmacol; 1987; 32(1):11-6. PubMed ID: 3034622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisinopril dose-response relationship in essential hypertension.
    Gomez HJ; Cirillo VJ; Sromovsky JA; Otterbein ES; Shaw WC; Rush JE; Chrysant SG; Gradman AH; Leon AS; MacCarthy EP
    Br J Clin Pharmacol; 1989 Oct; 28(4):415-20. PubMed ID: 2556172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisinopril in elderly patients with hypertension. Long term effects on renal and metabolic function.
    Laher MS
    Drugs; 1990; 39 Suppl 2():55-63. PubMed ID: 2160884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisinopril in elderly patients with hypertension.
    Laher MS; Natin D; Rao SK; Jones RW; Carr P
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S69-71. PubMed ID: 2442557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive response to lisinopril: the effect of age in a predominantly black population.
    Cummings DM; Amadio P; Taylor EJ; Balaban DJ; Rocci ML; Abrams WB; Feinberg J; Vlasses PH
    J Clin Pharmacol; 1989 Jan; 29(1):25-32. PubMed ID: 2540224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril (MK421) in the treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    J Hypertens Suppl; 1983 Oct; 1(1):109-17. PubMed ID: 6100599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study.
    Tomei R; Rossi L; Carbonieri E; Franceschini L; Molon G; Zardini P
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):911-4. PubMed ID: 1376812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacology of lisinopril.
    Gomez HJ; Cirillo VJ; Moncloa F
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S27-34. PubMed ID: 2442549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril in the treatment of renovascular hypertension.
    Knecht A; Grossman E; Rosenthal T
    Clin Exp Hypertens A; 1985; 7(10):1377-93. PubMed ID: 3000654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.